Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34737| Title: | Extended duration of letermovir prophylaxis: how long is long enough? | Austin Authors: | Douglas, Abby P;Slavin, Monica A | Affiliation: | National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;. National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Department of Health Services Research and Implementation Science, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Department of Infectious Diseases, University of Melbourne, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne VIC, Australia. Infectious Diseases |
Issue Date: | Feb-2024 | Date: | 2023 | Publication information: | The Lancet. Haematology 2024-02; 11(2) | URI: | https://ahro.austin.org.au/austinjspui/handle/1/34737 | DOI: | 10.1016/S2352-3026(23)00368-X | ORCID: | Journal: | The Lancet. Haematology | PubMed URL: | 38142694 | ISSN: | 2352-3026 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.